Список литературы

1. Смулевич А.Б. Расстройства личности. Рациональная фармакотерапия в психиатрической практике. Руководство для практикующих врачей. - М.: Литтера, 2014. - С. 458 - 493.

2. Смулевич А.Б. Расстройства личности. Психиатрия. Национальное руководство. - М.: ГЭОТАР-Медиа, 2018. - С. 663 - 668.

3. Рубинштейн С.Я. Экспериментальные методики патопсихологии и опыт применения их в клинике. - М.: Изд. Института психотерапии. 2010. - 414 с.

4. Linehan M.M., Amstrong H.E., Suarez A, Allmon D, Heard H.L. 1991. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 48: 1060 - 1064.

5. Linehan M.M., Tutek D.A., Heard H.L., Armstrong H.E. 1994. Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. Am J Psychiatry 151: 1771 - 1776.

6. Linehan M.M. Schmidt H. 3rd, Dimeff L.A., Craft J.C., Kanter J. Comtois K.A. 1999. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict 8: 279 - 292.

7. Linehan M.M., Dimeff L.A., Reynolds S.K., et al. 2002. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend 67: 13 - 26.

8. Linehan M.M., Comtois K.A., Murray A.M., et al. 2006. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 63: 757 - 766.

9. Verheul R, Van Den Bosch L.M., Koeter M.W., De Ridder M.A., Stijnen T., Van Den Brink W. 2003. Dialectical behavior therapy for women with borderline personality disorder: 12-month, randomised clinical trial in the netherlands. Br J Psychiatry 182: 135 - 140.

10. Bosch L.M., Koeter M.W., Stijnen T., Verheul R., van den Brink W. 2005. Substained efficacy of dialectical behavior therapy for borderline personality disorder. Behav Res Ther 43: 1231 - 1241.

11. Bateman A., Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am. J. Psychiatry. 2009; 166(12): 1355 - 1364.

12. Bateman A., Fonagy P. Personality Disorders: Theory, Research and Treatment A Randomized Controlled Trial of a Mentalization-Based Borderline Personality Disorder A Randomized Controlled Trial of a Mentalization-Based Intervention (MBT-FACTS) for Families of People With. 2019; 10(1): 70.

13. C., Kalgren L., Sandell A., F., Philips B. Mentalization-based therapy adherence and competence stimulates in-session mentalization in psychotherapy for borderline personality disorder with co-morbid substance dependence. Trials. 2016/07/14 ed. 2017; 27(6): 749 - 765.

14. Philips B, Wennberg P, Konradsson P, Franck J. Mentalization-Based Treatment for Concurrent Borderline Personality Disorder and Substance Use Disorder: A Randomized Controlled Feasibility Study. Eur Addict Res. 2018/02/07 ed. 2018; 24(1): 1 - 8.

15. Kvarstein EH, Pedersen G, Folmo E, Urnes , Johansen MS, Hummelen B, et al. Mentalization-based treatment or psychodynamic treatment programmes for patients with borderline personality disorder - the impact of clinical severity. Psychol Psychother Theory Res Pract. 2018. 1 - 21.

16. Бурно А.А. Практическое руководство по Терапии творческим самовыражением/Под. ред. М.Е. Бурно, Е.А. Добролюбовой. - М.: Академический Проект, ОППЛ, 2003. - С. 342 - 347.

17. Бурно М.Е. Клиническая психотерапия. Изд. 2-е, доп. и перераб. - М.: Академический проект; Деловая книга, 2006;

18. Иговская А.С. Краткая история клинической психотерапии пациентов со специфическими расстройствами личности с преобладанием ипохондрии//Мед. психология в России. 2012. N 2 (13). - С. 1 - 4.

19. Кернберг О.Ф. Тяжелые личностные расстройства. Стратегии психотерапии. Severe Personality Disorders: Psychotherapeutic Strategies. - Москва: Независимая фирма "Класс", 2001. - 464 с.

20. Stoffers JM, Vollm BA, Rucker G et al. Pharmacological intervention for borderline personality disorder. Cochrane Database Syst Rev 2010.

21. Ingenhoven T., Lafay P., Rinne T. et al. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials//J. Clin. Psychiatry. 2010. Vol. 71. P. 14 - 25.

22. Смулевич А.Б. Расстройства личности. Траектория в пространстве психической и соматической патологии. - М.: МИА, 2012. - 336 с.

23. Gardner D.L., Cowdry R.W.: Alprazolam-induced dyscontrol in borderline personality disorder. Am J Psychiatry 1985; 142: 98 - 100.

24. Cowdry R.W., Gardner D.L.: Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988; 45: 111 - 119.

25. Herpertz SC, Zanarini M, Schulz CS, Siever L, Lieb K, HJ; WFSBP Task Force on Personality Disorders; World Federation of Societies of Biological Psychiatry (WFSBP). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007; 8(4): 212 - 44.

26. Арана Дж., Розенбаум Дж. Фармакотерапия психических расстройств. Пер. с англ. М.: "Издательство БИНОМ", 2006. - 416 с.

27. Stahl S.M. Stahl"s essential psychopharmacology: neuroscientific basis and practical applications. Cambridge university press, 2013.

28. Alapin B., Stanczak T. Neuleptil (propericiazine) - a correcting drug in behavior disorders. Preliminary report (article in Polish). Neurologia, Neurochirurgiai Psychiatria Polska 1966; 16 (10): 1167 - 1171;

29. Daneel A.B. Neulactil (pericyazine) in the behaviour disturbances of institutionalized mental defectives. SAJ Med Sci 1967; 41 (39): 995 - 998;

30. Nardini L, Pistoni A. Selectivity of action of propericiazine in behavior disorders (article in Italian). Rivista Sperimentale Freniatria Medicina Legale Alienazioni Mentali. 1967; 91 (2): 569 - 575;

31. Nimb M. Proceedings of a symposium on behavioural disorders held in Leeds. Ed. F.A.Jenner. Dagenham, 1965; p. 21;

32. Rasch P.J. Treatment of disorders of character and schizophrenia by pericyazine (Neulactil). Acta Psychiatr Scand. (Suppl.) 1966; 191: 200 - 215;

33. Villa J.L., Nouri A. Therapy of personality problems and behavior in the aged with a phenothiazine derivative (neuleptil) (article in French). Praxis 1967; 56 (44): 1500 - 1510;

34. Volmat R. Proceedings of a symposium on behavioural disorders held in Leeds. Ed. F.A.Jenner. Dagenham, 1965; p. 30; Wallis GG. Proceedings of a symposium on behavioural disorders held in Leeds. Ed. F.A.Jenner. Dagenham, 1965; p. 26;

35. Ionescu R, Nica S.U., Oproiu L. et al. Double-blind study in psychopathic behavior disorders (clozapine and pericyazine). Pharmakopsychiatrie Neuropsychopharmakologie 1973; 6 (6): 294 - 9,

36. Калинин В.В. Неулептил: применение в клинической практике. Социальная и клиническая психиатрия. 1993; 3(3): 134 - 138.

37. Данилов Д.С. Эффективность и переносимость терапии перициазином больных шизотипическим расстройством, органическим расстройством личности и пациентов с патохарактерологическими нарушениями в рамках расстройств личности. Журн. неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (10): 65 - 71.

38. Soloff P.H., Cornelius J., George A., Nathan S., Perel J.M., Ulrich R.F.: Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993; 50: 377 - 385.

39. Duivenvoorden H. J. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains//Journal of clinical psychopharmacology. - 2011. - Т. 31. - N. 4. - С. 489 - 496.

40. Cornelius J.R., Soloff P.H., Perel J.M., Ulrich R.F.: Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. Am J Psychiatry 1993; 150: 1843 - 1848.

41. Rocca P., Marchiaro L., Bogetto F. Treatment of borderline personality disorder with risperidone//The Journal of clinical psychiatry. - 2002. - Т. 63. - N. 3. - С. 241 - 244.

42. Hallmayer J. F. Risperidone and borderline personality disorder//Current psychiatry reports. - 2003. - Т. 5. - N. 3. - С. 175 - 176.

43. Bogenschutz M.P., George Nurnberg H. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry. 2004; 65: 104 - 109;

44. Zanarini M.C., Frankenburg F.R. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2001; 62: 849 - 854.

45. Zanarini M.C., Frankenburg F.R., Parachini E.A. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004; 65: 903 - 907;

46. Linehan M.M., McDavid J.D., Brown M.Z., et al. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2008; 69: 999 - 1005;

47. Shafti S.S., Shahveisi B. Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial. J Clin Psychopharmacol. 2010; 30: 44 - 47;

48. Soler J., Pascual J.C., Campins J., et al. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry. 2005; 162: 1221 - 1224.

49. Bogenschutz MP, George Nurnberg H. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry. 2004; 65: 104 - 109;

50. Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2001; 62: 849Y854,

51. Zanarini M.C., Frankenburg F.R., Parachini E.A. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004; 65: 903 - 907.

52. Nickel M.K, Muehlbacher M, Nickel C, et al. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2006; 163: 833 - 838.

53. Nickel M.K. Aripiprazole treatment of patients with borderline personality disorder. J Clin Psychiatry. 2007; 68: 1815 - 1816.

54. Frankenburg F., Zanarini M.C.: Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 1993; 34: 402 - 405.

55. Benedetti F., Sforzini L., Colombo C., Maffei C., Smeraldi E.: Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998; 59: 103 - 107.

56. Chengappa K.N., Baker R.W.: The successful use of clozapine in ameliorating severe self mutilation in a patient with borderline personality disorder. J Personal Disord 1995; 9: 76 - 82.

57. Frankenburg F.R., Zanarini M.C. Clozapine treatment of borderline patients: a preliminary study//Comprehensive Psychiatry. - 1993. - Т. 34. - N. 6. - С. 402 - 405.

58. Pascual J.C., Soler J., Puigdemont D., et al. Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. J Clin Psychiatry. 2008; 69: 603 - 608.

59. Tritt K, Nickel C, Lahmann C, et al. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol. 2005; 19: 287 - 291.

60. Leiberich P, Nickel MK, Tritt K, et al. Lamotrigine treatment of aggression in female borderline patients. Part II: An 18-month follow-up. J Psychopharmacol. 2008; 22: 805 - 808.

61. Reich DB, Zanarini MC, Bieri KA. A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. Int Clin Psychopharmacol 2009; 24 (5): 270 - 5.

62. Loew T.H., Nickel M.K., Muehlbacher M., et al. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2006; 26: 61 - 66.

63. Nickel M.K., Nickel C., Mitterlehner F.O., et al. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Clin Psychiatry. 2004; 65: 1515 - 1519.

64. Nickel M.K., Nickel C., Kaplan P. et al. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol. Psychiatry. 2005; 57: 495 - 499;

65. Nickel M. Topiramate reduced aggression in female patients with borderline personality disorder. Eur Arch Psychiatry Clin Neurosci. 2007; 257: 432 - 433.

66. Nickel MK, Loew TH. Treatment of aggression with topiramate in male borderline patients. Part II: 18-month follow-up. Eur Psychiatry. 2008; 23: 115 - 117.

67. de la Fuente JM, Lotstra F. 1994. A Trial of carbamazepine in borderline personality disorder. Eur. Neuropsychopharmacol 4: 470 - 486.

68. Nose M. et al. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials //International clinical psychopharmacology. - 2006. - Т. 21. - N. 6. - С. 345 - 353.

69. Vita A., De Peri L., Sacchetti E. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials//Journal of Clinical Psychopharmacology. - 2011. - Т. 31. - N. 5. - С. 613 - 624.

70. Tang T.Z., DeRubeis R.J., Hollon S.D. et al. Personality change during depression treatment: a placebo-controlled trial//Arch. Gen. Psychiatry. 2009. Vol. 66. P. 1322 - 1330.

71. Salzmann C., Wolfson A.N., Schatzberg A., et al. 1995. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 15: 23 - 29.

72. Coccaro E.F., Kavoussi R.J. 1997. Fluoxetine and impulsive aggressive behaviour in personality-disordered subjects. Arch Gen Psychiatry 54: 1081 - 1088.

73. Fan A.H., Hassell J. Bipolar disorder and comorbid personality psychopathology: a review of the literature to examine the prevalence of personality disorder comorbidity in bipolar disorder and examine the effects of this comorbidity on bipolar disorder patients//J. Clin. Psychiatry. 2008. Vol. 69, N 11. P. 1794 - 803.

74. Zanarini M.C., Frankenburg F.R., Parachini E.A. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004; 65: 903 - 907.

75. Ekselius L., von Knorring L. Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram//Int. Clin. Psychopharmacol. 1998. Vol. 13, N 5. P. 205 - 211.

76. Soloff P.H., George A., Nathan S., Schulz P.M., Cornelius J.R., Herring J., Perel J.M.: Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol 1989; 9: 238 - 246;

77. Обухов С.Г. Психиатрия/Под ред. Ю.А. Александровского - М.: ГЭОТАР-Медиа, 2007. - 352 с.

78. Смулевич А.Б. Расстройства личности. Рациональная фармакотерапия в психиатрической практике. Руководство для практикующих врачей. - М.: Литтера, 2014. - С. 458 - 493.

79. Bateman, A. and Fonagy, P. (1999). Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 156: 1563 - 1569;

80. Chiesa, M. and Fonagy, P. (2003). Psychosocial treatment for severe personality disorder: 36-month follow-up. Br J Psychiatry 183: 356 - 362.

81. Spong A. J. et al. Brief psychological interventions for borderline personality disorder. A systematic review and meta-analysis of randomised controlled trials//Clinical psychology review. - 2020. - С. 101937.

82. Gibbon S. et al. Psychological interventions for antisocial personality disorder//Cochrane Database of Systematic Reviews. - 2020. - N. 9.

83. McLaughlin S. P. B. et al. Group psychotherapy for borderline personality disorder: A meta-analysis of randomized-controlled trials//Psychotherapy. - 2019. - Т. 56. - N. 2. - С. 260.

84. Cristea I. A. et al. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis//Jama psychiatry. - 2017. - Т. 74. - N. 4. - С. 319 - 328.

85. Barnicot K. et al. Treatment completion in psychotherapy for borderline personality disorder-a systematic review and meta-analysis//Acta Psychiatrica Scandinavica. - 2011. - Т. 123. - N. 5. - С. 327 - 338.

86. Kliem S., C., Kosfelder J. Dialectical behavior therapy for borderline personality disorder: a meta-analysis using mixed-effects modeling//Journal of consulting and clinical psychology. - 2010. - Т. 78. - N. 6. - С. 936.

87. Oud M. et al. Specialized psychotherapies for adults with borderline personality disorder: a systematic review and meta-analysis //Australian & New Zealand Journal of Psychiatry. - 2018. - Т. 52. - N. 10. - С. 949 - 961.

88. Chakhssi F. et al. Effect of psychotherapy for borderline personality disorder on quality of life: a systematic review and meta-analysis//Journal of personality disorders. - 2021. - Т. 35. - N. 2. - С. 255 - 269.

89. Wilson H. A. Can antisocial personality disorder be treated? A meta-analysis examining the effectiveness of treatment in reducing recidivism for individuals diagnosed with ASPD//International Journal of Forensic Mental Health. - 2014. - Т. 13. - N. 1. - С. 36 - 46.

90. Oltmanns J. R. et al. General factors of psychopathology, personality, and personality disorder: Across domain comparisons//Clinical psychological science. - 2018. - Т. 6. - N. 4. - С. 581 - 589.

91. Derksen J., Sloore H. Psychodiagnostics and Indications for Treatment in Cases of Personality Disorder//Treatment of personality disorders. - Springer, Boston, MA, 1999. - С. 155 - 166.